Mr. Speaker, by no means did our government wait at all. Increasing our country's bio-manufacturing capacity has been part of our recovery plan since the very beginning. It is in our interest, both now and in the future, to have this capability within our borders.
That is why, at the beginning of this crisis, at the beginning of the pandemic, we made immediate investments in bio-manufacturing projects in Quebec City with Medicago, VIDO-InterVac in Saskatchewan, the National Research Council, of course, and with AbCellera.
We have moved quickly to make sure that our bio-manufacturing is much stronger after years of disinvestment. Today's announcement with Novavax is just another bit of good news. Our government is taking a step-by-step approach with advice from our national—